A Targeted Drug Delivery System for Treatment of Bone Metastasis

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1141602

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The most common site where cancer spreads is the bone. Once it happens, it can dramatically affect patient’s quality of life and chance of survival. Current treatments are mostly palliative or associate with acute side effects due to systematic administration of anticancer drugs and their inability to selectively target the diseased area. This study aims to develop a nanocarrier that can uptake, protect and deliver anticancer drugs to the affected site in bone.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2019

Funding Scheme: Project Grants

Funding Amount: $243,607.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Nanomedicine

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

bone cancer | cancer chemotherapeutic agents | cancer control | metastatic cancer | nanotechnology

Related Links